^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Ovidrel (choriogonadotropin alfa)

    i
    Other names: rhCG
    Associations

    News

    Trials
    Company:
    EMD Serono
    Drug class:
    Ovarian follicle modulator
    Associations

    News

    Trials
    over2years
    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS (clinicaltrials.gov)
    P1, N=144, Recruiting, University of Virginia | Trial completion date: May 2024 --> May 2026 | Trial primary completion date: Apr 2024 --> Apr 2026
    Trial completion date • Trial primary completion date
    |
    Ovidrel (choriogonadotropin alfa)
    over2years
    Ovarian Contribution to Androgen Production in Adolescent Girls (clinicaltrials.gov)
    P=N/A, N=80, Active, not recruiting, University of Virginia | Recruiting --> Active, not recruiting | Trial completion date: Dec 2022 --> Dec 2025 | Trial primary completion date: Dec 2022 --> Dec 2025
    Enrollment closed • Trial completion date • Trial primary completion date
    |
    Ovidrel (choriogonadotropin alfa) • dexamethasone injection